retatrutide success stories They Lied to You About — Belly Fat After 40 Retatrutide vs. tirzepatide: how they're

Hagemann D, Meier JJ, Gallwitz B, Schmidt WE

thyroid cancer or hyperthyroidism, gastroparesis, pancreatic cancer or pancreatitis, MEN2 syndrome, or inflammatory bowel disease)

World Health Organ Tech Rep Ser 2000

"The ability of semaglutide to significantly lower cardiovascular and COVID-19-related adverse events underscores the transformative potential of targeting obesity and improving cardiometabolic health as a strategy to protect against a broad spectrum of health threats." In the sex differences substudy, researchers found females experienced fewer major adverse cardiovascular events compared to males, but semaglutide consistently reduced the risk of adverse cardiovascular outcomes regardless of sex

Major Findings: Produced significant dose-dependent reductions in HbA1c